カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の複合経口避妊薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Combined Oral Contraceptive Pill Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY8772）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY8772
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の複合経口避妊薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

複合経口避妊薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の複合経口避妊薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

複合経口避妊薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・長時間作用型避妊薬、短時間作用型避妊薬

用途別セグメントは次のように区分されます。
・病院、ドラッグストア、オンライン販売

世界の複合経口避妊薬市場の主要な市場プレーヤーは以下のとおりです。
・Bayer、Paladin Labs、Foundation Consumer Healthcare、Theramex (Teva)、Pfizer、Apotex、HRA Pharma、HLL Life Care、Syzygy Healthcare、V Care Pharma、Allergan、Lupin、Mankind、Piramal、Zhejiang Xianju Pharmaceutical Co

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、複合経口避妊薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な複合経口避妊薬メーカーの企業概要、2019年～2022年までの複合経口避妊薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な複合経口避妊薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別複合経口避妊薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの複合経口避妊薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での複合経口避妊薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および複合経口避妊薬の産業チェーンを掲載しています。
・第13、14、15章では、複合経口避妊薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Paladin Labs、Foundation Consumer Healthcare、Theramex (Teva)、Pfizer、Apotex、HRA Pharma、HLL Life Care、Syzygy Healthcare、V Care Pharma、Allergan、Lupin、Mankind、Piramal、Zhejiang Xianju Pharmaceutical Co
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：長時間作用型避妊薬、短時間作用型避妊薬
・用途別分析2017年-2028年：病院、ドラッグストア、オンライン販売
・複合経口避妊薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・複合経口避妊薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・複合経口避妊薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・複合経口避妊薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・複合経口避妊薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Combined Oral Contraceptive Pill market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Combined Oral Contraceptive Pill market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Combined Oral Contraceptive Pill global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Long-acting Contraceptives segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Combined Oral Contraceptive Pill include Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Combined Oral Contraceptive Pill market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Long-acting Contraceptives
Short-acting Contraceptives
Market segment by Application can be divided into
Hospital
Drug Store
Online Sale
The key market players for global Combined Oral Contraceptive Pill market are listed below:
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
HLL Life Care
Syzygy Healthcare
V Care Pharma
Allergan
Lupin
Mankind
Piramal
Zhejiang Xianju Pharmaceutical Co
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Combined Oral Contraceptive Pill product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Combined Oral Contraceptive Pill, with price, sales, revenue and global market share of Combined Oral Contraceptive Pill from 2019 to 2022.
Chapter 3, the Combined Oral Contraceptive Pill competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Combined Oral Contraceptive Pill breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Combined Oral Contraceptive Pill market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Combined Oral Contraceptive Pill.
Chapter 13, 14, and 15, to describe Combined Oral Contraceptive Pill sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Combined Oral Contraceptive Pill Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Combined Oral Contraceptive Pill Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Long-acting Contraceptives
1.2.3 Short-acting Contraceptives
1.3 Market Analysis by Application
1.3.1 Overview: Global Combined Oral Contraceptive Pill Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Sale
1.4 Global Combined Oral Contraceptive Pill Market Size & Forecast
1.4.1 Global Combined Oral Contraceptive Pill Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Combined Oral Contraceptive Pill Sales in Volume (2017-2028)
1.4.3 Global Combined Oral Contraceptive Pill Price (2017-2028)
1.5 Global Combined Oral Contraceptive Pill Production Capacity Analysis
1.5.1 Global Combined Oral Contraceptive Pill Total Production Capacity (2017-2028)
1.5.2 Global Combined Oral Contraceptive Pill Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Combined Oral Contraceptive Pill Market Drivers
1.6.2 Combined Oral Contraceptive Pill Market Restraints
1.6.3 Combined Oral Contraceptive Pill Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Combined Oral Contraceptive Pill Product and Services
2.1.4 Bayer Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Paladin Labs
2.2.1 Paladin Labs Details
2.2.2 Paladin Labs Major Business
2.2.3 Paladin Labs Combined Oral Contraceptive Pill Product and Services
2.2.4 Paladin Labs Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Foundation Consumer Healthcare
2.3.1 Foundation Consumer Healthcare Details
2.3.2 Foundation Consumer Healthcare Major Business
2.3.3 Foundation Consumer Healthcare Combined Oral Contraceptive Pill Product and Services
2.3.4 Foundation Consumer Healthcare Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Theramex (Teva)
2.4.1 Theramex (Teva) Details
2.4.2 Theramex (Teva) Major Business
2.4.3 Theramex (Teva) Combined Oral Contraceptive Pill Product and Services
2.4.4 Theramex (Teva) Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Combined Oral Contraceptive Pill Product and Services
2.5.4 Pfizer Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Combined Oral Contraceptive Pill Product and Services
2.6.4 Apotex Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 HRA Pharma
2.7.1 HRA Pharma Details
2.7.2 HRA Pharma Major Business
2.7.3 HRA Pharma Combined Oral Contraceptive Pill Product and Services
2.7.4 HRA Pharma Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 HLL Life Care
2.8.1 HLL Life Care Details
2.8.2 HLL Life Care Major Business
2.8.3 HLL Life Care Combined Oral Contraceptive Pill Product and Services
2.8.4 HLL Life Care Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Syzygy Healthcare
2.9.1 Syzygy Healthcare Details
2.9.2 Syzygy Healthcare Major Business
2.9.3 Syzygy Healthcare Combined Oral Contraceptive Pill Product and Services
2.9.4 Syzygy Healthcare Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 V Care Pharma
2.10.1 V Care Pharma Details
2.10.2 V Care Pharma Major Business
2.10.3 V Care Pharma Combined Oral Contraceptive Pill Product and Services
2.10.4 V Care Pharma Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Combined Oral Contraceptive Pill Product and Services
2.11.4 Allergan Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Lupin
2.12.1 Lupin Details
2.12.2 Lupin Major Business
2.12.3 Lupin Combined Oral Contraceptive Pill Product and Services
2.12.4 Lupin Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Mankind
2.13.1 Mankind Details
2.13.2 Mankind Major Business
2.13.3 Mankind Combined Oral Contraceptive Pill Product and Services
2.13.4 Mankind Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Piramal
2.14.1 Piramal Details
2.14.2 Piramal Major Business
2.14.3 Piramal Combined Oral Contraceptive Pill Product and Services
2.14.4 Piramal Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Zhejiang Xianju Pharmaceutical Co
2.15.1 Zhejiang Xianju Pharmaceutical Co Details
2.15.2 Zhejiang Xianju Pharmaceutical Co Major Business
2.15.3 Zhejiang Xianju Pharmaceutical Co Combined Oral Contraceptive Pill Product and Services
2.15.4 Zhejiang Xianju Pharmaceutical Co Combined Oral Contraceptive Pill Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Combined Oral Contraceptive Pill Breakdown Data by Manufacturer
3.1 Global Combined Oral Contraceptive Pill Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Combined Oral Contraceptive Pill Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Combined Oral Contraceptive Pill
3.4 Market Concentration Rate
3.4.1 Top 3 Combined Oral Contraceptive Pill Manufacturer Market Share in 2021
3.4.2 Top 6 Combined Oral Contraceptive Pill Manufacturer Market Share in 2021
3.5 Global Combined Oral Contraceptive Pill Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Combined Oral Contraceptive Pill Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Combined Oral Contraceptive Pill Market Size by Region
4.1.1 Global Combined Oral Contraceptive Pill Sales in Volume by Region (2017-2028)
4.1.2 Global Combined Oral Contraceptive Pill Revenue by Region (2017-2028)
4.2 North America Combined Oral Contraceptive Pill Revenue (2017-2028)
4.3 Europe Combined Oral Contraceptive Pill Revenue (2017-2028)
4.4 Asia-Pacific Combined Oral Contraceptive Pill Revenue (2017-2028)
4.5 South America Combined Oral Contraceptive Pill Revenue (2017-2028)
4.6 Middle East and Africa Combined Oral Contraceptive Pill Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Combined Oral Contraceptive Pill Sales in Volume by Type (2017-2028)
5.2 Global Combined Oral Contraceptive Pill Revenue by Type (2017-2028)
5.3 Global Combined Oral Contraceptive Pill Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Combined Oral Contraceptive Pill Sales in Volume by Application (2017-2028)
6.2 Global Combined Oral Contraceptive Pill Revenue by Application (2017-2028)
6.3 Global Combined Oral Contraceptive Pill Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Combined Oral Contraceptive Pill Sales by Type (2017-2028)
7.2 North America Combined Oral Contraceptive Pill Sales by Application (2017-2028)
7.3 North America Combined Oral Contraceptive Pill Market Size by Country
7.3.1 North America Combined Oral Contraceptive Pill Sales in Volume by Country (2017-2028)
7.3.2 North America Combined Oral Contraceptive Pill Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Combined Oral Contraceptive Pill Sales by Type (2017-2028)
8.2 Europe Combined Oral Contraceptive Pill Sales by Application (2017-2028)
8.3 Europe Combined Oral Contraceptive Pill Market Size by Country
8.3.1 Europe Combined Oral Contraceptive Pill Sales in Volume by Country (2017-2028)
8.3.2 Europe Combined Oral Contraceptive Pill Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Combined Oral Contraceptive Pill Sales by Type (2017-2028)
9.2 Asia-Pacific Combined Oral Contraceptive Pill Sales by Application (2017-2028)
9.3 Asia-Pacific Combined Oral Contraceptive Pill Market Size by Region
9.3.1 Asia-Pacific Combined Oral Contraceptive Pill Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Combined Oral Contraceptive Pill Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Combined Oral Contraceptive Pill Sales by Type (2017-2028)
10.2 South America Combined Oral Contraceptive Pill Sales by Application (2017-2028)
10.3 South America Combined Oral Contraceptive Pill Market Size by Country
10.3.1 South America Combined Oral Contraceptive Pill Sales in Volume by Country (2017-2028)
10.3.2 South America Combined Oral Contraceptive Pill Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Combined Oral Contraceptive Pill Sales by Type (2017-2028)
11.2 Middle East & Africa Combined Oral Contraceptive Pill Sales by Application (2017-2028)
11.3 Middle East & Africa Combined Oral Contraceptive Pill Market Size by Country
11.3.1 Middle East & Africa Combined Oral Contraceptive Pill Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Combined Oral Contraceptive Pill Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Combined Oral Contraceptive Pill and Key Manufacturers
12.2 Manufacturing Costs Percentage of Combined Oral Contraceptive Pill
12.3 Combined Oral Contraceptive Pill Production Process
12.4 Combined Oral Contraceptive Pill Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Combined Oral Contraceptive Pill Typical Distributors
13.3 Combined Oral Contraceptive Pill Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の避妊薬市場2022年：市場規模予測（～2028年）
  • 世界の複合綿入り包帯市場2022年：市場規模予測（～2028年）
  • 世界のスマートピルディスペンサー市場2022年：市場規模予測（～2028年）
  • 世界の複合計器用変圧器市場2022年：市場規模予測（～2028年）
  • デジタル避妊薬の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY8772 )"世界の複合経口避妊薬市場2022年：市場規模予測（～2028年）" (英文：Global Combined Oral Contraceptive Pill Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。